10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001683168-17-003031`
Period End Date	20170930
Filing Date	20171114
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	xbio-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 68 Cash Flow Statement 85

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Cash	`Cash`	$211.90K	USD	Point-in-time
Cash	`Cash`	$132.23K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.73M	shares	Point-in-time
Cash	`Cash`	$4.05M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.04M	shares	Point-in-time
Cash	`Cash`	$694.75K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.72M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.41M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.00M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$42.50K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.22M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$1.25M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.34M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.05M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$42.37K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$32.29K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$66.34K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$31.83K	USD	Point-in-time
Total assets	`Assets`	$20.97M	USD	Point-in-time
Total assets	`Assets`	$14.64M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.01M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.03M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$838.89K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.11M	USD	Point-in-time
Deferred revenue and other current liabilities	`DeferredCreditsAndOtherLiabilitiesCurrent`	$20.20K	USD	Point-in-time
Deferred revenue and other current liabilities	`DeferredCreditsAndOtherLiabilitiesCurrent`	$21.07K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.16M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$19.88K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$4.98K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.80M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.08M	USD	Point-in-time
Commitments and contingent liabilities (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of September 30, 2017 and December 31, 2016; 9,041,426 and 8,731,029 shares issued as of September 30, 2017 and December 31, 2016, respectively; 8,717,541 and 8,407,144 shares outstanding as of September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$8.73K	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of September 30, 2017 and December 31, 2016; 9,041,426 and 8,731,029 shares issued as of September 30, 2017 and December 31, 2016, respectively; 8,717,541 and 8,407,144 shares outstanding as of September 30, 2017 and December 31, 2016, respectively	`CommonStockValue`	$9.04K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$163.52M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$164.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-150.38M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-142.34M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.17M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.55M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$20.97M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.64M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Collaboration services	`OtherIncome`	$85.00K	USD	1 Quarter
Collaboration services	`OtherIncome`	$85.00K	USD	3 Qtrs
Collaboration services	`OtherIncome`	-	USD	1 Quarter
Collaboration services	`OtherIncome`	-	USD	3 Qtrs
Total revenues	`Revenues`	$85.00K	USD	1 Quarter
Total revenues	`Revenues`	-	USD	3 Qtrs
Total revenues	`Revenues`	$85.00K	USD	3 Qtrs
Total revenues	`Revenues`	-	USD	1 Quarter
Cost of research and development revenue	`CostsIncurredDevelopmentCosts`	$97.03K	USD	1 Quarter
Cost of research and development revenue	`CostsIncurredDevelopmentCosts`	$156.12K	USD	3 Qtrs
Cost of research and development revenue	`CostsIncurredDevelopmentCosts`	-	USD	1 Quarter
Cost of research and development revenue	`CostsIncurredDevelopmentCosts`	-	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$884.80K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.53M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.98M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$891.83K	USD	1 Quarter
In-process research and development expense	`OtherResearchAndDevelopmentExpense`	-	USD	1 Quarter
In-process research and development expense	`OtherResearchAndDevelopmentExpense`	$39.50M	USD	3 Qtrs
In-process research and development expense	`OtherResearchAndDevelopmentExpense`	-	USD	1 Quarter
In-process research and development expense	`OtherResearchAndDevelopmentExpense`	-	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.34M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.36M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.34M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.95M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-8.00M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.24M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.25M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-47.37M	USD	3 Qtrs
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	-	USD	3 Qtrs
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	$241.30K	USD	1 Quarter
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	-	USD	1 Quarter
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	$2.15M	USD	3 Qtrs
Loss on issuance of hybrid debt instrument	`GainLossOnIssuanceOfHybridDebtInstrument`	$-1.69M	USD	3 Qtrs
Loss on issuance of hybrid debt instrument	`GainLossOnIssuanceOfHybridDebtInstrument`	-	USD	1 Quarter
Loss on issuance of hybrid debt instrument	`GainLossOnIssuanceOfHybridDebtInstrument`	$-106.57K	USD	1 Quarter
Loss on issuance of hybrid debt instrument	`GainLossOnIssuanceOfHybridDebtInstrument`	-	USD	3 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	$-6.19M	USD	3 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-13.44K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-49.61K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-26.99K	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-14.98K	USD	1 Quarter
Interest income	`InterestIncomeOther`	-	USD	1 Quarter
Interest income	`InterestIncomeOther`	$10.20K	USD	3 Qtrs
Interest income	`InterestIncomeOther`	$31.00	USD	3 Qtrs
Interest income	`InterestIncomeOther`	$4.00	USD	1 Quarter
Interest expense	`InterestExpense`	$1.47K	USD	3 Qtrs
Interest expense	`InterestExpense`	$341.65K	USD	1 Quarter
Interest expense	`InterestExpense`	$690.12K	USD	3 Qtrs
Interest expense	`InterestExpense`	$425.00	USD	1 Quarter
Total other non-operating expense	`NonoperatingIncomeExpense`	$-15.40K	USD	1 Quarter
Total other non-operating expense	`NonoperatingIncomeExpense`	$-40.88K	USD	3 Qtrs
Total other non-operating expense	`NonoperatingIncomeExpense`	$-6.45M	USD	3 Qtrs
Total other non-operating expense	`NonoperatingIncomeExpense`	$-220.35K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-53.81M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.04M	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.26	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-7.54	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.93	USD	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.99M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.13M	shares	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.72M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.65M	shares	3 Qtrs

Cash Flow Statement 85 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-53.81M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.04M	USD	3 Qtrs
In-process research and development expense	`OtherResearchAndDevelopmentExpense`	-	USD	1 Quarter
In-process research and development expense	`OtherResearchAndDevelopmentExpense`	$39.50M	USD	3 Qtrs
In-process research and development expense	`OtherResearchAndDevelopmentExpense`	-	USD	1 Quarter
In-process research and development expense	`OtherResearchAndDevelopmentExpense`	-	USD	3 Qtrs
Depreciation	`Depreciation`	$27.25K	USD	3 Qtrs
Depreciation	`Depreciation`	$5.00K	USD	1 Quarter
Depreciation	`Depreciation`	$9.00K	USD	1 Quarter
Depreciation	`Depreciation`	$19.34K	USD	3 Qtrs
Amortization of hybrid debt instrument discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amortization of hybrid debt instrument discount	`AmortizationOfDebtDiscountPremium`	$519.10K	USD	3 Qtrs
Non-cash interest expense	`OtherNoncashExpense`	$168.75K	USD	3 Qtrs
Share-based payments	`ShareBasedCompensation`	$1.52M	USD	3 Qtrs
Share-based payments	`ShareBasedCompensation`	$1.51M	USD	3 Qtrs
Warrant-based expense for services	`AdjustmentOfWarrantsGrantedForServices`	$-118.24K	USD	3 Qtrs
Warrant-based expense for services	`AdjustmentOfWarrantsGrantedForServices`	$1.12M	USD	3 Qtrs
Vendor share-based payments	`VendorSharebasedPayments`	$97.78K	USD	3 Qtrs
Vendor share-based payments	`VendorSharebasedPayments`	-	USD	3 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	3 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$241.30K	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$2.15M	USD	3 Qtrs
Loss on issuance of hybrid debt instruments	`GainLossOnIssuanceOfHybridDebtInstrument`	$-1.69M	USD	3 Qtrs
Loss on issuance of hybrid debt instruments	`GainLossOnIssuanceOfHybridDebtInstrument`	-	USD	1 Quarter
Loss on issuance of hybrid debt instruments	`GainLossOnIssuanceOfHybridDebtInstrument`	$-106.57K	USD	1 Quarter
Loss on issuance of hybrid debt instruments	`GainLossOnIssuanceOfHybridDebtInstrument`	-	USD	3 Qtrs
Hybrid debt instrument issuance costs	`HybridDebtInstrumentIssuanceCosts`	-	USD	3 Qtrs
Hybrid debt instrument issuance costs	`HybridDebtInstrumentIssuanceCosts`	$12.09K	USD	3 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	$-6.19M	USD	3 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Other non-cash transactions	`OtherNoncashIncomeExpense`	$40.61K	USD	3 Qtrs
Other non-cash transactions	`OtherNoncashIncomeExpense`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.96M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-43.68K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-13.27K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$214.38K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$997.50K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.34M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.16M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.26K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.61K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.26K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-14.61K	USD	3 Qtrs
Proceeds from issuance of debt	`ProceedsFromIssuanceOfDebt`	$4.50M	USD	3 Qtrs
Proceeds from issuance of debt	`ProceedsFromIssuanceOfDebt`	-	USD	3 Qtrs
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	$242.47K	USD	3 Qtrs
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.26M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	3 Qtrs
Net change in cash, excluding restricted cash	`CashPeriodIncreaseDecrease`	$79.67K	USD	3 Qtrs
Net change in cash, excluding restricted cash	`CashPeriodIncreaseDecrease`	$-3.35M	USD	3 Qtrs
Cash at beginning of period	`Cash`	$211.90K	USD	Point-in-time
Cash at beginning of period	`Cash`	$132.23K	USD	Point-in-time
Cash at beginning of period	`Cash`	$4.05M	USD	Point-in-time
Cash at beginning of period	`Cash`	$694.75K	USD	Point-in-time
Cash at end of period	`Cash`	$211.90K	USD	Point-in-time
Cash at end of period	`Cash`	$132.23K	USD	Point-in-time
Cash at end of period	`Cash`	$4.05M	USD	Point-in-time
Cash at end of period	`Cash`	$694.75K	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$1.55K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Convertible debt paid in common stock	`ConvertibleDebtPaidInCommonStock`	-	USD	3 Qtrs
Convertible debt paid in common stock	`ConvertibleDebtPaidInCommonStock`	$6.50M	USD	3 Qtrs
Interest paid in common stock	`SettlementOfAccruedInterestInCommonStock`	$227.83K	USD	3 Qtrs
Interest paid in common stock	`SettlementOfAccruedInterestInCommonStock`	-	USD	3 Qtrs
Issuance of warrants in connection with debt	`NoncashIssuanceOfWarrantsInConnectionWithDebt`	$2.11M	USD	3 Qtrs
Issuance of warrants in connection with debt	`NoncashIssuanceOfWarrantsInConnectionWithDebt`	-	USD	3 Qtrs
Recording of derivative liability in connection with debt	`NoncashRecordingOfDerivativeLiabilityInConnectionWithDebt`	-	USD	3 Qtrs
Recording of derivative liability in connection with debt	`NoncashRecordingOfDerivativeLiabilityInConnectionWithDebt`	$4.12M	USD	3 Qtrs
Common stock exchanged for Series A convertible preferred stock	`CommonStockExchangedForSeriesConvertiblePreferredStock`	-	USD	3 Qtrs
Common stock exchanged for Series A convertible preferred stock	`CommonStockExchangedForSeriesConvertiblePreferredStock`	$970.00	USD	3 Qtrs
Issuance of common stock for goods and services	`IssuanceOfCommonStockForGoodsAndServices`	$993.67K	USD	3 Qtrs
Issuance of common stock for goods and services	`IssuanceOfCommonStockForGoodsAndServices`	-	USD	3 Qtrs
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	-	USD	3 Qtrs
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	$65.98K	USD	3 Qtrs
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	-	USD	3 Qtrs
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$185.00	USD	3 Qtrs
Issuance of common stock for promissory note converted in 2016	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	$125.00	USD	3 Qtrs
Issuance of common stock for promissory note converted in 2016	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.